Inés López

966 citations
18 papers · 664 indexed · h-index 10

Inés López

17 papers receiving 652 citations

Peers

Inés López
Comparison fields: 5 of 63
  • Cancer Research 258
  • Oncology 280
  • Pulmonary and Respiratory Medicine 198
  • Molecular Biology 396
  • Pathology and Forensic Medicine 46
Replace Huili Chu with:
Huili Chu China
Marissa Shrader United States
Ruixuan Geng China
Kuan‐Li Wu Taiwan
Teppei Sugano Japan
Meisongzhu Yang China
Muhammad Alamgeer Australia
Kazuhiro Kitamura Japan
Tessa Y. S. Le Large Netherlands
Jugang Wu China
Inés López relative to Huili Chu China Huili Chu's profile →
Citations per field
00.5×1.5×
Huili Chu · 1×
Citations per year

Countries citing papers authored by Inés López

Since Specialization
Citations

This map shows the geographic impact of Inés López's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inés López with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inés López more than expected).

Fields of papers citing papers by Inés López

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inés López. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inés López. The network helps show where Inés López may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Inés López, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Inés López Line = papers co-authored together Inés López links everyone, so they are left out of the graph.

All Works

18 of 18 papers shown
#Work
1 20250
2 20251
3 20247
4 20231
5 2018227
6 20171
7 201731
8 201527
9 201415
10 201428
11 20132
12 201337
13 20139
14 20122
15 201235
16 20127
17 2011224
18 201010

About Inés López

Inés López is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Hepatology, having authored 18 papers that have together received 664 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer Cells and Metastasis (3 papers), Cancer-related molecular mechanisms research (3 papers), TGF-β signaling in diseases (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Ubiquitin and proteasome pathways (2 papers) and Circular RNAs in diseases (2 papers). The work is most often cited by research in Cancer Research (258 citations), Oncology (280 citations), Pulmonary and Respiratory Medicine (198 citations), Molecular Biology (396 citations) and Pathology and Forensic Medicine (46 citations). Inés López has collaborated with scholars based in Spain, Belgium and United States. Frequent co-authors include Ignacio Gil‐Bazo, Christian Rolfo, Marta Román, Iosune Baraibar, Silvestre Vicent, Ernest Nadal, Marisol González-Huarriz, Eva Bandrés, Jesús García‐Foncillas and Valentina Boni. Their work appears in journals such as Journal of Translational Medicine, Cancer Letters, Clinical Genitourinary Cancer, Molecular Cancer and Stem Cells.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026